PNC Financial Services Group Inc. Has $71,000 Stock Position in Sotera Health Company $SHC

PNC Financial Services Group Inc. lessened its holdings in Sotera Health Company (NASDAQ:SHC) by 35.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,343 shares of the company’s stock after selling 3,435 shares during the period. PNC Financial Services Group Inc.’s holdings in Sotera Health were worth $71,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in SHC. UMB Bank n.a. grew its holdings in shares of Sotera Health by 112.8% during the 2nd quarter. UMB Bank n.a. now owns 2,635 shares of the company’s stock valued at $29,000 after purchasing an additional 1,397 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its position in Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company’s stock valued at $31,000 after buying an additional 2,620 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of Sotera Health by 124.0% during the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company’s stock worth $37,000 after buying an additional 1,849 shares during the last quarter. Summit Securities Group LLC acquired a new position in shares of Sotera Health during the first quarter worth $67,000. Finally, Farther Finance Advisors LLC lifted its stake in shares of Sotera Health by 55.9% in the 2nd quarter. Farther Finance Advisors LLC now owns 9,861 shares of the company’s stock valued at $110,000 after acquiring an additional 3,534 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on SHC. JPMorgan Chase & Co. boosted their price objective on Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. BMO Capital Markets started coverage on shares of Sotera Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price objective for the company. Piper Sandler boosted their target price on shares of Sotera Health from $15.00 to $17.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th. Finally, Barclays upped their price target on shares of Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $17.80.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $15.65, for a total transaction of $187,800,000.00. Following the sale, the director owned 29,215,301 shares in the company, valued at $457,219,460.65. This represents a 29.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Pincus & Co. Warburg sold 12,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $181,320,000.00. Following the sale, the director directly owned 61,822,952 shares of the company’s stock, valued at $934,144,804.72. This represents a 16.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 32,000,000 shares of company stock valued at $490,000,000. Company insiders own 55.12% of the company’s stock.

Sotera Health Stock Performance

Shares of SHC stock opened at $17.35 on Tuesday. The stock has a market capitalization of $4.93 billion, a PE ratio of 91.32 and a beta of 1.81. The business’s 50 day simple moving average is $16.23 and its 200 day simple moving average is $14.26. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. Sotera Health Company has a one year low of $9.53 and a one year high of $17.78.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. Sotera Health had a net margin of 4.82% and a return on equity of 43.69%. The firm had revenue of $311.31 million for the quarter, compared to the consensus estimate of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. As a group, research analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.